Indonesian Biomedical Journal

署名政策规定,署名仅限于对研究的构思、设计、执行、分析、解释以及稿件撰写和修改做出重大贡献的人员,每位署名作者都应对研究和稿件撰写做出实质性智力贡献,并鼓励公开作者贡献。 模型中文摘要

Authorship provides credit for an author's contributions to a study and carries accountability. Authorship should be limited to those who have made a significant contribution to the conception, design, execution, analysis and interpretation, as well as manuscript preparation and revision. Transparency about the contributions of authors is encouraged. In order to qualify for authorship of the submi…

利益冲突政策要求,投稿时每位作者须披露任何可能引起对所报告工作或结论、含义、观点产生偏倚疑问的个人和/或经济利益、关系或其他情况。 模型中文摘要

A conflict of interest exists when professional judgment concerning a primary interest may be influenced by a secondary interest. These instructions are based on ICJME recommendation for scholarly work in medical journal: Author’s Conflict of Interest At the point of submission, InaBJ requires that each author reveal any personal and/or financial interests or connections, direct or indirect, or ot…

数据可用性政策鼓励作者共享与研究数据相关的信息(包括但不限于原始数据、处理后的数据、软件、算法、方案、方法和材料),并要求注册临床试验提供数据共享计划。 模型中文摘要

To enable the openness, transparency, reproducibility and verification of data, InaBJ encourages authors to share information related with their research data including, but not limited to: raw data, processed data, software, algorithms, protocols, methods and materials. InaBJ also requires data sharing plans for registered clinical trials. Any clinical trial study that enrolling participants must…

科研诚信政策指出,科学不端行为包括在研究提议、实施、评审或结果报告中捏造、篡改或剽窃,InaBJ将严肃对待并调查此类指控。 模型中文摘要

Scientific misconduct is a wilful violation of standard codes of scholarly conduct and ethical behaviour in the publication of professional scientific research, which includes fabrication, falsification, or plagiarism in proposing, performing, reviewing research, or in reporting research results. Misconduct represents a tremendous attack on the values upon which science is based, and will be taken…

许可政策规定,在InaBJ发表的作者须将作品版权转让给PERI,稿件被接受后作者在发表前任何阶段不得撤稿,稿件被拒时版权将归还作者。 模型中文摘要

Author/s who publish in InaBJ will transfer the copyright of their work to PERI. By submitting a manuscript, the author/s agree that the copyright of their manuscript is transferred to PERI, if and when the manuscript is accepted for publication. Once submitted to the journal, the author/s will not withdraw their manuscript at any stage prior to publication. However, the copyright will be released…

开放获取政策规定,InaBJ基于让公众免费获取研究有助于更广泛的全球知识交流的原则,对其内容提供即时开放获取。 模型中文摘要

InaBJ provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

同行评审政策规定,所有投稿将由两名或以上审稿人进行双盲同行评审,每篇稿件至少包含一名外部审稿人,作者可建议审稿人,但最终由栏目编辑独立选定。 模型中文摘要

All manuscripts submitted to InaBJ will be selected and double-blind peer-reviewed by two or more reviewers to present valuable and authentic findings in biomedical sciences. At least, an external reviewer will be included as the reviewer in each manuscript reviewing process. Author can suggest reviewer/s that not having publication together within five years and should not be member/s of the same…

剽窃政策规定,剽窃行为被严格禁止,所有投稿将通过Turnitin和/或Crossref Similarity Check进行剽窃筛查,若发现剽窃或捏造信息,出版方有权采取适当行动。 模型中文摘要

Plagiarism is strictly forbidden, and by submitting the manuscript for publication the author/s agree that the publishers have the legal right to take appropriate action against the author/s if plagiarism or fabricated information is discovered. All manuscripts submitted to InaBJ will be screened for plagiarism by using Turnitin and/or Crossref Similarity Check.